Chaofu Wang

3.6k total citations · 2 hit papers
97 papers, 1.2k citations indexed

About

Chaofu Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Chaofu Wang has authored 97 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 38 papers in Pulmonary and Respiratory Medicine and 24 papers in Pathology and Forensic Medicine. Recurrent topics in Chaofu Wang's work include Renal cell carcinoma treatment (16 papers), Lymphoma Diagnosis and Treatment (16 papers) and Renal and related cancers (16 papers). Chaofu Wang is often cited by papers focused on Renal cell carcinoma treatment (16 papers), Lymphoma Diagnosis and Treatment (16 papers) and Renal and related cancers (16 papers). Chaofu Wang collaborates with scholars based in China, United States and Spain. Chaofu Wang's co-authors include Luting Zhou, Xinchao Zhang, Xu Wang, Yue Zhang, Maoqiao Xiang, Fei Dong, Robert H. Young, Jun Zhou, W. Scott McDougal and Chin‐Lee Wu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chaofu Wang

89 papers receiving 1.2k citations

Hit Papers

Butyrate-producing Eubacterium rectale suppresses lymphom... 2022 2026 2023 2024 2022 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaofu Wang China 19 545 408 308 175 152 97 1.2k
Douglas J. Harrison United States 15 442 0.8× 429 1.1× 296 1.0× 121 0.7× 247 1.6× 50 1.1k
Hongxue Meng China 20 479 0.9× 262 0.6× 254 0.8× 93 0.5× 321 2.1× 102 1.4k
Lars Huber Switzerland 22 639 1.2× 751 1.8× 393 1.3× 288 1.6× 134 0.9× 45 1.8k
Yanming Zhang United States 23 932 1.7× 280 0.7× 249 0.8× 124 0.7× 571 3.8× 148 2.0k
Weihua Fu China 20 345 0.6× 358 0.9× 159 0.5× 257 1.5× 210 1.4× 82 1.1k
Kyungeun Kim South Korea 22 510 0.9× 316 0.8× 217 0.7× 256 1.5× 352 2.3× 87 1.2k
Shinichi Kitajima Japan 21 560 1.0× 290 0.7× 108 0.4× 343 2.0× 374 2.5× 47 1.5k
Masahide Yamamoto Japan 24 634 1.2× 247 0.6× 262 0.9× 234 1.3× 375 2.5× 103 1.8k
Ri‐Sheng Yu China 18 213 0.4× 246 0.6× 81 0.3× 244 1.4× 237 1.6× 94 1.2k
Chin‐Ann Johnny Ong Singapore 19 371 0.7× 283 0.7× 154 0.5× 508 2.9× 244 1.6× 68 1.1k

Countries citing papers authored by Chaofu Wang

Since Specialization
Citations

This map shows the geographic impact of Chaofu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaofu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaofu Wang more than expected).

Fields of papers citing papers by Chaofu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaofu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaofu Wang. The network helps show where Chaofu Wang may publish in the future.

Co-authorship network of co-authors of Chaofu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chaofu Wang. A scholar is included among the top collaborators of Chaofu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaofu Wang. Chaofu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Liu, Zebing, Chen Chen, Haimin Xu, et al.. (2025). Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in gastric adenosquamous carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(6). 1347–1355.
4.
Wang, Xuan, Siteng Chen, Zhengchuan Niu, et al.. (2024). SCGN recruits macrophages by regulating chemokine secretion in clear cell renal cell carcinoma. International Journal of Biological Sciences. 20(15). 5925–5938.
5.
Wang, Zheng, Anqi Li, Yujie Lu, et al.. (2024). Association of tumor immune infiltration and prognosis with homologous recombination repair genes mutations in early triple-negative breast cancer. Frontiers in Immunology. 15. 1407837–1407837. 2 indexed citations
6.
Yan, Fang, Qian Da, Hongmei Yi, et al.. (2024). Artificial intelligence-based assessment of PD-L1 expression in diffuse large B cell lymphoma. npj Precision Oncology. 8(1). 76–76. 7 indexed citations
7.
Shen, Xia, et al.. (2024). Non-neoplastic B-cell predominant lymphoid proliferations at the organs exposed to external environment mimicking lymphoma: A potential diagnostic pitfall. International Journal of Immunopathology and Pharmacology. 38. 1210484465–1210484465. 2 indexed citations
8.
Da, Qian, et al.. (2024). Surgical intervention of Lemierre’s syndrome: a case report and review of the literature. Journal of Medical Case Reports. 18(1). 265–265. 3 indexed citations
9.
Li, Xiangyun, et al.. (2023). Long non-coding RNA HIF1A-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma. Pathology - Research and Practice. 253. 154984–154984. 3 indexed citations
10.
Xing, Ke, Wenxue Liu, Lisong Shen, et al.. (2023). Early Screening of Colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis. Biosensors. 13(7). 685–685. 3 indexed citations
11.
Zhu, Ping, Guoping Liu, Xue Wang, et al.. (2022). Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis. BMC Cancer. 22(1). 1283–1283. 18 indexed citations
12.
Xu, Haimin, Yue Fan, Xiangyun Li, et al.. (2022). GATA3 aids in distinguishing fumarate hydratase-deficient renal cell carcinoma from papillary renal cell carcinoma. Annals of Diagnostic Pathology. 60. 152007–152007. 9 indexed citations
13.
Zhou, Jun, et al.. (2021). Terminal Deoxynucleotidyl Transferase Commonly Expresses in Germ Cell Tumors: Evaluation on a Large Series from Multiple Centers. International Journal of General Medicine. Volume 14. 119–129. 3 indexed citations
14.
Yu, Yaren, Hao Zhang, Yun Song, et al.. (2019). Plasma retinol and the risk of first stroke in hypertensive adults: a nested case-control study. American Journal of Clinical Nutrition. 109(2). 449–456. 19 indexed citations
15.
Deng, Yu, Yong Wu, Ping Zhao, et al.. (2019). <p>The Nrf2/HO-1 axis can be a prognostic factor in clear cell renal cell carcinoma</p>. Cancer Management and Research. Volume 11. 1221–1230. 17 indexed citations
16.
Cao, Yiwen, Zhenhua Liu, Wen Wu, et al.. (2019). Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma. Frontiers of Medicine. 13(1). 94–103. 1 indexed citations
17.
Xiang, Maoqiao, et al.. (2016). Grain growth behavior of Li4SiO4 pebbles fabricated by agar method for tritium breeder. Fusion Engineering and Design. 112. 513–519. 11 indexed citations
18.
Dai, Bo, Kun Chang, Yunyi Kong, et al.. (2015). [Analysis of biochemical recurrence following radical prostatectomy].. PubMed. 53(4). 261–5. 1 indexed citations
19.
Xiang, Maoqiao, Yingchun Zhang, Yun Zhang, et al.. (2015). Preparation of Li2TiO3–Li4SiO4 core–shell ceramic pebbles with enhanced crush load by graphite bed process. Journal of Nuclear Materials. 466. 477–483. 38 indexed citations
20.
Bian, Xiaojie, Yijun Shen, Guiming Zhang, et al.. (2015). Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer. PLoS ONE. 10(3). e0120159–e0120159. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026